Biopure Corporation
Biotech Specialty Pharma
11 Hurley Street
Cambridge, MA 02141 USA
phone: (617) 234-6500
fax: (617) 234-6505
Symbol BPUR
Exchange NASDAQ
Founded 0
Employees 164
www.biopure.com
Research Sector Biotech Specialty Pharma
Summary Description
Biopure Corporation is a developer of oxygen therapeutics.
Management
Zafiris G. Zafirelis, Chairman, President and Chief Executive Officer; Francis H. Murphy, Chief Financial Officer; Jane Kober Senior Vice President, General Counsel and Secretary; Geoffrey J. Filbey, Vice President, Engineering; A. Gerson Greenburg, M.D., Ph.D., Vice President, Medical Affairs; W. Richard Light, Ph.D., Vice President, Technology Development; Virginia T. Rentko, V.M.D., Vice President, Preclinical Development; Barry L. Scott, Vice President, Business Development
Ownership
Financials Mkt Cap :115


* numbers in thousands

 
Keywords
oxygen, blood substitutes, hemoglobin

Comment | Printable Version | Mar. 05, 2007
If you work for Biopure Corporation and want to update this profile, click here


Description
Biopure Corporation is a developer, manufacturer and supplier of a new class of pharmaceuticals, called oxygen therapeutics, which are intravenously administered to deliver oxygen to the body's tissues. Using its proprietary technology, the Company has developed and manufactures two products: Hemopure (hemoglobin glutamer - 250 (bovine), or HBOC-201) for human use, and Oxyglobin (hemoglobin glutamer - 200 (bovine), or HBOC-301) for veterinary use. Biopure's products are made from hemoglobin that has been extracted from bovine red blood cells and then purified, chemically modified and cross-linked for stability. The resulting hemoglobin solutions do not contain red blood cells and, for the final product, are formulated in a balanced salt solution similar to Ringer's lactate.


2008-11-20-143